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Thought starters: 
I have had the honor of having several executive leadership institute scholars join me 
for a typical day, whatever that is.  I think that what they see is that while there are 
somewhat predictable seasons in the life of a university, much of what we do requires 
that you make a decision based on your best judgment, relying also on the wisdom and 
experience of those on your team.  Sometimes, you are in unchartered territory.  You 
go back to your values and your commitments, and act upon them. 
 
Sharing one significant challenge that you overcame that helped you grow: 
Possibly the requirement of speaking to so many groups and individuals (about 175 
times a year), and that you profess that you are basically (or used to be) a private 
person.  The requirement that you be an ambassador for Georgia Tech can be both 
energizing and draining. 
 
The need to act fast (your comment about the average tenure of a university president) 
 
Example of taking a strong stand: (3 possible suggestions) 
• Gun control 
• The need for a tuition increase 
• Immigration reform  
 
Your comment about when you came to Tech you discovered it was really a series of 





Your advice on leadership at the leaders’ offsite on achieving One Georgia Tech: 
“Leadership includes vision.  In 10 years, what we accomplish will depend on what all 
of you do today — the people you work with, the students and faculty we attract, what 
we do on a daily basis, and how we work together as One Georgia Tech.   
One GT won’t just happen.  We have to drive it.” 
 
 Your comments after “A Conversation Among Presidents”: 
On April 25 I joined with several of my colleagues from universities in the Atlanta area 
to engage in a conversation about ethics.  The discussion grew out of a challenge from 
Dr. William Foege, the 2012 recipient of Georgia Tech’s Ivan Allen Prize for Social 
Courage, to emphasize the human-centered nature of science and technology while 
we conduct our research and our teaching, and in the way we do our jobs and equip 
the next generation to face some of the world’s greatest challenges. 
 
Ethics and compassion cannot be separated from science and technology.  The driving 
force behind the discoveries in science and the applications in engineering and 
technology is the need to improve the human condition.   
 
Dr. Foege is crediting with leading the eradication of smallpox throughout the world.  In 
doing so, he implemented a surveillance and containment method that had not been 
tested on a global scale.  He was successful in Africa, in the face of criticism, and then 
in India, amidst even more criticism and political pressure.  He also led the CDC’s effort 
in an aggressive communication strategy about the AIDS virus shortly after it was 
discovered, at a time when many top leaders advised him not to.  
 
The challenge, and the commitment needed, is to do the right thing, regardless.  Ethics 
can be compared to tennis.  Either it is in, or it is out.  While there are many hard 
decisions along the way about which choice is the most ethical, a good leader’s 
decision should never be whether or not to remain ethical. 
 
If there were anything that could muddle the line, it would be compassion.  We can 
look to Dr. Foege again for an example. Through leadership in the CDC, the Carter 
Center and the Task Force for Child Survival, he oversaw the eradication of Guinea 
worm disease, polio and measles, and the elimination of river blindness; and 
advocated policies that vastly accelerated childhood immunization in developing 
countries.  While executive director of the Carter Center, he was a trailblazer in getting 
a pharmaceutical company to provide a drug invented to treat heartworm in dogs to be 
used overseas to treat river blindness in humans.  Again, the move was controversial.  
We only need to look at the results.  Twenty-seven million people in more than 23 
African and Latin American countries are now being treated yearly.  Several 
pharmaceutical companies are now providing free medicine to millions in developing 
countries. 
 
While a global thinker, Dr. Foege is known for being able to see, and take into account, 
the faces of people. He once asked, “What is better than science?”  His answer: 
“Better than science is science with heart, science with ethics, science with equity, 
science with justice.” 
